Third-party disability
Showing 1 - 25 of >10,000
Viral Infection, Viral Reactivation, Infection in an Immunocompromised Host Trial in Cincinnati (Viral Specific VST Infusion)
Recruiting
- Viral Infection
- +2 more
- Viral Specific VST Infusion
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Apr 7, 2022
Stem Cell Transplantation Trial in Durham (Thymic Transplantation for Recipients of UCB transplant)
Terminated
- Stem Cell Transplantation
- Thymic Transplantation for Recipients of UCB transplant
-
Durham, North CarolinaDuke University Health System
Mar 21, 2022
Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell
Recruiting
- Recurrent Adult T-Cell Leukemia/Lymphoma
- +3 more
- Cyclophosphamide
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 18, 2022
Inflammatory Bowel Disease Trial in Beijing (450mg, 150mg, Placebo)
Completed
- Inflammatory Bowel Disease
- 450mg
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jul 7, 2022
Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,
Recruiting
- Hodgkin Disease
- +5 more
- MABEL CTLs
- +2 more
-
Houston, Texas
- +1 more
Jan 13, 2023
Osteoarthritis Trial in United States (Bone Marrow Derived MSCs, Adipose-derived MSCs, Umbilical Cord Tissue (UCT) MSCs)
Completed
- Osteoarthritis
- Bone Marrow Derived MSCs
- +3 more
-
Gulf Breeze, Florida
- +4 more
Jul 5, 2022
Covid19 Trial in Philadelphia (Cytotoxic T Lymphocytes)
Active, not recruiting
- Covid19
- Cytotoxic T Lymphocytes
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 15, 2022
COVID-19 Trial in Santo André (Meplazumab for Injection, Sterile normal saline (0.9%))
Recruiting
- COVID-19
- Meplazumab for Injection
- Sterile normal saline (0.9%)
-
Santo André, Sao Paulo, BrazilPesquisare Saúde
Jun 2, 2022
Generation of Antigen-specific T-lymphocyte Cell Lines From
Terminated
- Healthy
- Leukapheresis
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 2, 2021
Hematological Malignancies, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (PBSCs, Cord, BMSCs)
Recruiting
- Hematological Malignancies
- Hematopoietic Stem Cell Transplantation
- PBSCs
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Mar 13, 2022
Mental Health Impairment, Mental Health Disorder, Psychosocial Problem Trial in Kailahun, Koinadugu, Kono (YRI+Entrepreneurship
Active, not recruiting
- Mental Health Impairment
- +2 more
- Youth Readiness Intervention (YRI)
- Entrepreneurship Training
-
Kailahun, Sierra Leone
- +2 more
Jan 3, 2023
Anxiety Trial in Toulouse (Early device / Follow up, Usual care)
Completed
- Anxiety
- Early device / Follow up
- Usual care
-
Toulouse, FranceUniversity Hospital Toulouse
Nov 9, 2020
Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Recurrent Acute Myeloid
Recruiting
- Allogeneic Stem Cell Transplant Recipient
- +3 more
- Cytarabine Hydrochloride
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 7, 2022
Aged; Disable; Exercise; Rehabilitation; Wheelchair Trial in Taichung (Cycling wheelchair)
Completed
- Aged; Disable; Exercise; Rehabilitation; Wheelchair
- Cycling wheelchair
-
Taichung, TaiwanTaichung Veterans General Hospital
Aug 2, 2022
Quality of Life, Lymphedema, Hand Grasp Trial (Complex Decongestive Treatment, Sham transcutaneous vagus nerve stimulation,
Not yet recruiting
- Quality of Life
- +5 more
- Complex Decongestive Treatment
- +3 more
- (no location specified)
Sep 29, 2023
Osteogenesis Imperfecta, Osteogenesis Imperfecta Type III Trial (Bone marrow-derived mesenchymal stromal cells (MSCs))
Not yet recruiting
- Osteogenesis Imperfecta
- Osteogenesis Imperfecta Type III
- Bone marrow-derived mesenchymal stromal cells (MSCs)
- (no location specified)
Nov 28, 2022
Genetic Disease, Nonsense Mutation Trial in Antwerp (ELX-02, Placebo)
Completed
- Genetic Disease
- Nonsense Mutation
- ELX-02
- Placebo
-
Antwerp, BelgiumSGS Life Sciences, Clinical Pharmacology Unit
Feb 23, 2021
Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)
Recruiting
- Myeloid Malignancies
- +3 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Caner Center
Nov 17, 2022
Personalized, Predictive, Precise & Preventive Medicine for
Not yet recruiting
- Major Depressive Disorder
- Persistent Depressive Disorder
- (no location specified)
Sep 5, 2023
Cerebral Adrenoleukodystrophy Trial in Minneapolis (Mesenchymal stem cells (IV-MSC))
Recruiting
- Cerebral Adrenoleukodystrophy
- Mesenchymal stem cells (IV-MSC)
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Sep 7, 2023
Overactive Bladder Trial in Zurich (Tolterodine, Filling cystometry, Intravesical neurostimulation)
Completed
- Overactive Bladder
- Tolterodine
- +2 more
-
Zurich, SwitzerlandPfizer Investigational Site
Jan 26, 2021
Diet, Healthy Trial in Kajang (A 12-week parallel dietary intervention)
Completed
- Diet
- Healthy
- A 12-week parallel dietary intervention
-
Kajang, Selangor, MalaysiaMalaysian Palm Oil Board
Mar 28, 2023
SARS-CoV2 Infection Trial in India (COVAXIN)
Completed
- SARS-CoV2 Infection
- COVAXIN
-
Visakhapatnam, Andhra Pradesh, India
- +6 more
Aug 17, 2022
Distal Radius Fracture Trial in Kirsehir (Telerehabilitation, Face to face)
Recruiting
- Distal Radius Fracture
- Telerehabilitation
- Face to face
-
Kirşehir, City Centre, TurkeyAhi Evran University
Sep 9, 2022